Compile Data Set for Download or QSAR
Report error Found 138 Enz. Inhib. hit(s) with all data for entry = 13040
LigandPNGBDBM754051((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 2nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754039((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 3nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754051((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 3nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754032(US20250206761, Example RM461)
Affinity DataIC50: 4nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754051((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 7nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754067(US20250206761, Example 45)
Affinity DataIC50: 10nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754039((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 10nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754071(1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[[(7S,...)
Affinity DataIC50: 15nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754035(US20250206761, Example RM44)
Affinity DataIC50: 17nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754055((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 18nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754076(1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[[(7S,...)
Affinity DataIC50: 19nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754041(1-[(2R)-2-chloro-2-fluoro-acetyl]-4-fluoro-N-[(1S)...)
Affinity DataIC50: 20nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754065((2S)-2-[(5R)-7-[(2R)-2-chloro-2-fluoro-acetyl]-1-o...)
Affinity DataIC50: 22nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754057((2S)-2-[(5S)-7-[(2R)-2-chloro-2-fluoro-acetyl]-1-o...)
Affinity DataIC50: 23nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754033(US20250206761, Example RM461-A)
Affinity DataIC50: 27nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754060(US20250206761, Example 38)
Affinity DataIC50: 32nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754066(1-[(2R)-2-chloro-2-fluoro-acetyl]-4-fluoro-N-[(1S)...)
Affinity DataIC50: 34nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754058((2S)-2-[9-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 38nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754052((2S)-2-[(5S)-7-[(2R)-2-chloro-2-fluoro-acetyl]-1-o...)
Affinity DataIC50: 38nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754059((2S)-2-[2-[(2R)-2-chloro-2-fluoro-acetyl]-5-oxo-2,...)
Affinity DataIC50: 39nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754077((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 40nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754053(US20250206761, Example 31)
Affinity DataIC50: 44nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754042((2S)-2-[2-[(2R)-2-chloro-2-fluoro-acetyl]-5-oxo-2,...)
Affinity DataIC50: 45nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754050((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 46nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754070((2S)-2-[9-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 47nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754056(1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[[(7S,...)
Affinity DataIC50: 47nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754048((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 53nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754054((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 56nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754075(US20250206761, Example 53)
Affinity DataIC50: 56nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754047(US20250206761, Example 23)
Affinity DataIC50: 64nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754044(US20250206761, Example 18)
Affinity DataIC50: 71nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754064((2S)-2-[9-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 73nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754073((2S)-2-[(5R)-7-[(2R)-2-chloro-2-fluoro-acetyl]-1-o...)
Affinity DataIC50: 74nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754069((2S)-2-[8-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 79nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754039((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 85nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754063((2S)-2-[[1-[(2R)-2-chloro-2-fluoro-acetyl]azetidin...)
Affinity DataIC50: 88nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754037((3S)-1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[...)
Affinity DataIC50: 89nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754049((2S)-2-[2-[(2R)-2-chloro-2-fluoro-acetyl]-5-oxo-2,...)
Affinity DataIC50: 98nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754043((2S)-2-[(5S)-2-[(2R)-2-chloro-2-fluoro-acetyl]-6-o...)
Affinity DataIC50: 100nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754061((2S)-2-[8-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 104nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754062((2R)-2-[[1-[(2R)-2-chloro-2-fluoro-acetyl]azetidin...)
Affinity DataIC50: 108nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754074((2S)-2-[2-[(2R)-2-chloro-2-fluoro-acetyl]-5-oxo-2,...)
Affinity DataIC50: 115nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754038((2S)-2-[(5S)-7-[(2R)-2-chloro-2-fluoro-acetyl]-1-o...)
Affinity DataIC50: 122nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754072((2S)-2-[8-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 124nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754068((2S)-2-[2-[(2R)-2-chloro-2-fluoro-acetyl]-5-oxo-2,...)
Affinity DataIC50: 129nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754041(1-[(2R)-2-chloro-2-fluoro-acetyl]-4-fluoro-N-[(1S)...)
Affinity DataIC50: 136nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754045((2S)-2-[9-[(2R)-2-chloro-2-fluoro-acetyl]-1-oxo-2,...)
Affinity DataIC50: 148nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754040(1-[(2R)-2-chloro-2-fluoro-acetyl]-4-fluoro-N-[(1S)...)
Affinity DataIC50: 176nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754046((2S)-2-[(5R)-2-[(2S)-2-chloro-2-fluoro-acetyl]-6-o...)
Affinity DataIC50: 199nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

LigandPNGBDBM754076(1-[(2R)-2-chloro-2-fluoro-acetyl]-N-[(1S)-1-[[(7S,...)
Affinity DataIC50: 217nMAssay Description:In this example, TR-FRET was also used to measure the compound or compound-CYPA dependent disruption of the KRAS G12C-BRAF complex. This protocol was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

Displayed 1 to 50 (of 138 total ) | Next | Last >>
Jump to: